Long-term administration of PPI reduces treatment failures after esophageal variceal band ligation: A randomized, controlled trial

Journal of Gastroenterology

Volumn 47, Issue 2, 2012, Pages 118-126

  Hidaka, Hisashi ^a   Nakazawa, Takahide ^a   Wang, Guoqin ^b   Kokubu, Shigehiro ^c   Minamino, Tsutomu ^a   Takada, Juichi ^a   Tanaka, Yoshiaki ^a   Okuwaki, Yusuke ^a   Watanabe, Masaaki ^a   Tanabe, Satoshi ^a   Shibuya, Akitaka ^a   Koizumi, Wasaburo ^a  

^a KITASATO UNIVERSITY HOSPITAL   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endoscopic variceal ligation; Portal hypertension; Proton pump inhibitor; Rabeprazole

Indexed keywords

ANTIBIOTIC AGENT; LANSOPRAZOLE; RABEPRAZOLE; STEROID; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DYSPHAGIA; ELECTIVE SURGERY; ESOPHAGEAL VARICEAL BAND LIGATION; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HEMORRHOID; HUMAN; LIGATION; LONG TERM CARE; MALE; MORNING DOSAGE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SCORING SYSTEM; TREATMENT FAILURE; UNIVERSITY HOSPITAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; INTENTION TO TREAT ANALYSIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE PERIOD;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGED; COMBINED MODALITY THERAPY; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; LIGATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROTON PUMP INHIBITORS; TREATMENT FAILURE;

EID: 84862304855     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-011-0472-0     Document Type: Article

References (26)

1. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med. 1988;319:983-9.
2. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis. 1999;19:475-505. (Pubitemid 30032646)
3. Garcia-Tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding-unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference. Hepatology. 2008;47:1764-72.
4. Bolognesi M, Balducci G, Garcia-Tsao G, Gatta A, Gines P, Merli M, et al. Complications in the medical treatment of portal hypertension. Portal hypertension III. In: Proceedings of the third Baveno international consensus workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell Science; 2001. p. 180-203.
5. Khuroo MS, Khuroo NS, Farahat KL, Khuroo YS, Sofi AA, Dahab ST. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther. 2005;21:347-61. (Pubitemid 40313938)
6. Stiegman GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med. 1992;326:1527-32.
7. Gimson AE, Ramage JK, Panos MZ, Hayllar K, Harrison PM, Williams R, et al. Randomized trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet. 1993;342:391-4. (Pubitemid 23236351)
8. Cotton PB, Williams CB. Practical gastrointestinal endoscopy. Cambridge: Blackwell Science; 1996.
9. Shaheen NJ, Stuart E, Schmitz SM, Mitchell KL, Fried MW, Zacks S, et al. Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology. 2005;41:588-94. (Pubitemid 40289507)
10. Tajiri T, Yoshida H, Obara K, Onji M, Kage M, Kitano S, et al. General rules for recording endoscopic findings of esophagogastric varices. 2nd ed. Dig Endosc. 2010;22:1-9.
11. Yoshida H, Mamada Y, Taniai N, Yamamoto K, Kawano Y, Mizuguchi Y, et al. A randomized control trial of bi-monthly versus bi-weekly endoscopic variceal ligation of esophageal varices. Am J Gastroenterol. 2005;100:2005-9.
12. Jutabha R, Jensen DM, Martin P, Savides T, Han SH, Gornbein J. Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. Gastroenterology. 2005;128:870-81. (Pubitemid 40523540)
13. Bosch J, Mastai R, Kravetz D, Navasa M, Rodés J. Hemodynamic evaluation of the patient with portal hypertension. Semin Liver Dis. 1986;6:309-17. (Pubitemid 17219026)
14. Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med. 1999;340:988-93. (Pubitemid 29157630)
15. Bosch J, García-Pagán JC. Prevention of variceal rebleeding. Lancet. 2003;15(361):952-4. (Pubitemid 36332114)
16. Schepke M, Kleber G, Nurnberg D, Willert J, Koch L, VeltzkeSchlieker W, et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2004; 40:65-72. (Pubitemid 38868924)
17. Thuluvath PJ, Maheshwari A, Jagannath S, Arepally A. A randomized controlled trial of beta-blockers versus endoscopic band ligation for primary prophylaxis: a large sample size is required to show a difference in bleeding rates. Dig Dis Sci. 2005;50: 407-10. (Pubitemid 40311556)
18. Norberto L, Polese L, Cillo U, Grigoletto F, Burroughs AK, Neri D, et al. A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. Liver Transpl. 2007;13:1272-8. (Pubitemid 47457054)
19. Young MF, Sanowski RA, Rasche R. Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy. Gastrointest Endosc. 1993;39:119-22. (Pubitemid 23139700)
20. Ahmed AM, al Karawi MA, Shariq S, Mohamed AE. Frequency of gastroesophageal reflux in patients with liver cirrhosis. Hepatogastroenterology. 1993;40:478-80. (Pubitemid 23310270)
21. Grande L, Planas R, Lacima G, Boix J, Ros E, Esteve M, et al. Sequential esophageal motility studies after endoscopic injection sclerotherapy: a prospective investigation. Am J Gastroenterol. 1991;86:36-40.
22. Sandy H, Kirsten MA. Esophageal acid-clearance and motility after endoscopic sclerotherapy of esophageal varices. Am J Gastroenterol. 1986;81:419-22.
23. Sauerbruch T, Wirsching R, Leisner B, Weinzierl M, Pfahler M, Paumgartner G. Esophageal function after sclerotherapy of bleeding varices. Scand J Gastroenterol. 1982;17:745-51. (Pubitemid 12052319)
24. Hou MC, Yen TC, Lin HC, Kuo BI, Chen CH, Lee FY, et al. Sequential changes ofesophageal motility after endoscopic injection sclerotherapy or variceal ligation for esophageal variceal bleeding: a scintigraphic study. Am J Gastroenterol. 1997;92:1875-8. (Pubitemid 27440910)
25. Spence RA, Smith JA, Isaacs S, Terblanche J. Disturbed oesophageal motility after eradication of varices by chronic sclerotherapy - a scintigraphic study. S Afr Med J. 1990;77:138-40. (Pubitemid 20181974)
26. Hoyumpa AM, Trevino-Alanis H, Grimes I, Humphries TJ. Rabeprazole: pharmacokinetics in patients with stable, compensated cirrhosis. Clin Ther. 1999;21:691-701. (Pubitemid 29252091)